OBJECTIVE: To examine the incidence of and risk factors for device-associated infections and associated mortality. DESIGN AND SETTING: Prospective surveillance-based study in ICUs of 19 hospitals in The Netherlands. PATIENTS: The study included 2,644 patients without infection at admission during 1997-2000, staying in the ICU for at least 48 h. MEASUREMENTS AND RESULTS: The occurrence of ventilator-associated pneumonia (VAP), central venous catheter (CVC) related bloodstream infection (CR-BSI), urinary catheter-associated urinary tract infection (CA-UTI) and risk factors was monitored. Of the ventilated patients 19% developed pneumonia (25/1,000 ventilator days); of those with a central line 3% developed CR-BSI (4/1,000 CVC days,) and of catheterized patients 8% developed CA-UTI (9/1,000 catheter days). Longer device use increased the risk for all infections, especially for CR-BSI. Independent risk factors were sex, immunity, acute/elective admission, selective decontamination of the digestive tract, and systemic antibiotics at admission, dependent upon the infection type. Crude mortality significantly differed in patients with and without CR-BSI (31% vs. 20%) and CA-UTI (27% vs. 17%) but not for VAP (26% vs. 23%). Acquiring a device-associated infection was not an independent risk factor for mortality. Being in need of ventilation or a central line, and the duration of this, contributed significantly to mortality, after adjusting for other risk factors. CONCLUSIONS: Device use was the major risk factor for acquiring VAP, CR-BSI and CA-UTI. Acquiring a device-associated infection was not an independent risk factor for mortality, but device use in itself was.
OBJECTIVE: To examine the incidence of and risk factors for device-associated infections and associated mortality. DESIGN AND SETTING: Prospective surveillance-based study in ICUs of 19 hospitals in The Netherlands. PATIENTS: The study included 2,644 patients without infection at admission during 1997-2000, staying in the ICU for at least 48 h. MEASUREMENTS AND RESULTS: The occurrence of ventilator-associated pneumonia (VAP), central venous catheter (CVC) related bloodstream infection (CR-BSI), urinary catheter-associated urinary tract infection (CA-UTI) and risk factors was monitored. Of the ventilated patients 19% developed pneumonia (25/1,000 ventilator days); of those with a central line 3% developed CR-BSI (4/1,000 CVC days,) and of catheterized patients 8% developed CA-UTI (9/1,000 catheter days). Longer device use increased the risk for all infections, especially for CR-BSI. Independent risk factors were sex, immunity, acute/elective admission, selective decontamination of the digestive tract, and systemic antibiotics at admission, dependent upon the infection type. Crude mortality significantly differed in patients with and without CR-BSI (31% vs. 20%) and CA-UTI (27% vs. 17%) but not for VAP (26% vs. 23%). Acquiring a device-associated infection was not an independent risk factor for mortality. Being in need of ventilation or a central line, and the duration of this, contributed significantly to mortality, after adjusting for other risk factors. CONCLUSIONS: Device use was the major risk factor for acquiring VAP, CR-BSI and CA-UTI. Acquiring a device-associated infection was not an independent risk factor for mortality, but device use in itself was.
Authors: Marc Leone; Jacques Albanèse; Franck Garnier; Christophe Sapin; Karine Barrau; Marie-Christine Bimar; Claude Martin Journal: Intensive Care Med Date: 2003-04-09 Impact factor: 17.440
Authors: J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer Journal: JAMA Date: 1995 Aug 23-30 Impact factor: 56.272
Authors: Corsino Rey; Francisco Alvarez; Victoria De-La-Rua; Andrés Concha; Alberto Medina; Juan-José Díaz; Sergio Menéndez; Marta Los-Arcos; Juan Mayordomo-Colunga Journal: Intensive Care Med Date: 2011-01-27 Impact factor: 17.440
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-01-31 Impact factor: 17.440
Authors: K Kaier; C Wilson; M Hulscher; H Wollersheim; A Huis; M Borg; E Scicluna; M-L Lambert; M Palomar; E Tacconelli; G De Angelis; M Schumacher; M Wolkewitz; E-M Kleissle; U Frank Journal: Infection Date: 2011-08-30 Impact factor: 3.553
Authors: Heinz Burgmann; J Michael Hiesmayr; Anne Savey; Peter Bauer; Barbara Metnitz; Philipp G H Metnitz Journal: Intensive Care Med Date: 2010-07-08 Impact factor: 17.440
Authors: Philippe Seguin; Bruno Laviolle; Sonia Isslame; Aurélie Coué; Yannick Mallédant Journal: Intensive Care Med Date: 2010-03-18 Impact factor: 17.440
Authors: Jose Garnacho-Montero; Teresa Aldabó-Pallás; Mercedes Palomar-Martínez; Jordi Vallés; Benito Almirante; Rafael Garcés; Fabrio Grill; Miquel Pujol; Cristina Arenas-Giménez; Eduard Mesalles; Ana Escoresca-Ortega; Marina de Cueto; Carlos Ortiz-Leyba Journal: Intensive Care Med Date: 2008-07-12 Impact factor: 17.440